- Home
- PMCB vs HUSA Comparison
PMCB vs HUSA Comparison
Compare PMCB & HUSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- HUSA
- Stock Information
- Founded
- PMCB 1996
- HUSA N/A
- Country
- PMCB United States
- HUSA United States
- Employees
- PMCB N/A
- HUSA N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- HUSA Oil & Gas Production
- Sector
- PMCB Health Care
- HUSA Energy
- Exchange
- PMCB Nasdaq
- HUSA Nasdaq
- Market Cap
- PMCB 11.4M
- HUSA 9.6M
- IPO Year
- PMCB N/A
- HUSA N/A
- Fundamental
- Price
- PMCB $1.19
- HUSA $0.58
- Analyst Decision
- PMCB
- HUSA
- Analyst Count
- PMCB 0
- HUSA 0
- Target Price
- PMCB N/A
- HUSA N/A
- AVG Volume (30 Days)
- PMCB 17.9K
- HUSA 397.1K
- Earning Date
- PMCB 03-17-2025
- HUSA 05-14-2025
- Dividend Yield
- PMCB N/A
- HUSA N/A
- EPS Growth
- PMCB N/A
- HUSA N/A
- EPS
- PMCB 1.29
- HUSA N/A
- Revenue
- PMCB N/A
- HUSA $560,180.00
- Revenue This Year
- PMCB N/A
- HUSA N/A
- Revenue Next Year
- PMCB N/A
- HUSA N/A
- P/E Ratio
- PMCB $0.89
- HUSA N/A
- Revenue Growth
- PMCB N/A
- HUSA N/A
- 52 Week Low
- PMCB $1.05
- HUSA $0.50
- 52 Week High
- PMCB $2.42
- HUSA $3.20
- Technical
- Relative Strength Index (RSI)
- PMCB 39.44
- HUSA 29.50
- Support Level
- PMCB $1.05
- HUSA $0.50
- Resistance Level
- PMCB $1.27
- HUSA $0.60
- Average True Range (ATR)
- PMCB 0.12
- HUSA 0.07
- MACD
- PMCB 0.00
- HUSA 0.01
- Stochastic Oscillator
- PMCB 37.21
- HUSA 26.66
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About HUSA Houston American Energy Corporation
Houston American Energy Corp is an independent oil and gas company focused on the development, exploration, exploitation, acquisition, and production of natural gas and crude oil properties. Its properties, and operations, are in the U.S. Permian Basin, the U.S. Gulf Coast region, particularly Louisiana, and the South American country of Colombia. Geographically, the company currently has operations in two geographical areas, the United States, from where it derives maximum revenue, and Colombia.